首页> 外文期刊>Applied biochemistry and microbiology >Expression and Purificaton of Multi-toxin Fusion Protein of Clostridium perfringens and the Preparation of Genetically Engineered Multivalent Subunit Vaccine
【24h】

Expression and Purificaton of Multi-toxin Fusion Protein of Clostridium perfringens and the Preparation of Genetically Engineered Multivalent Subunit Vaccine

机译:梭菌梭菌的多毒素融合蛋白的表达及纯化及基因工程多价亚基疫苗的制备

获取原文
获取原文并翻译 | 示例
           

摘要

Currently, there is an urgent need to develop genetically engineered multivalent subunit vaccines or DNA vaccines to provide protection against infection of multiple types of Clostridium perfringens. In this study, we expressed the fusion protein of -2-epsilon-toxin derived from C. perfringens in Escherichia coli. For the first time, an efficient expression of a soluble -2-epsilon-toxin in E. coli was obtained after codon optimization, removal of the signal peptide and optimization of the expression conditions. Increased level of antibodies was detected in the serum of mice after immunization with the expressed protein. The immunized mice were protected from C. perfringens type A, B, C and D infections with the survival rate of 100, 100, 90and 100%, respectively.
机译:目前,迫切需要开发基因工程的多价亚基疫苗或DNA疫苗,以提供免受多种类型的梭菌的感染。 在这项研究中,我们表达了来自大肠杆菌中的C.流量的-2-epsilon-毒素的融合蛋白。 首次,在密码子优化后,获得在大肠杆菌中的可溶性-2-epsilon-毒素的有效表达,除去信号肽和表达条件的优化。 在用表达蛋白质免疫后,在小鼠血清中检测到抗体水平增加。 免疫小鼠免疫的小鼠免受C.流产型A,B,C和D感染,其存活率分别为100,100,90和100%。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号